Rznomics

Rznomics

Developing gene therapy for liver cancer, general cancer, degenerative disease,genetic diseases in order to realize human disease conquest through the development of innovative RNA-based bio drugs.

HQ location
Yongin-si, South Korea
Launch date
Employees
Enterprise value
$156m
Company register number
5318100949
Authorizing premium user...